Navigation Links
Noesis Health Introduces AdvancedSMAT for Better Management of Cloverleaf Message Files
Date:7/14/2008

ealth
Panama City, Florida-based Noesis Health (www.noesishealth.com) is a national healthcare solutions company that helps organizations transform their business through systems interoperability, process improvements and strategic information technology. The company's strategic consulting uses a unique combination of technology expertise and a tailored approach so that healthcare organizations can capitalize on existing IT investments.

For media inquiries:
Jene' Leiner
The Cypress Group
jleiner@cypressgroup1.com
651-330-1724

AdvancedSMAT is a trademark of Noesis Health. Other product or service names mentioned herein are the trademarks of their respective owners.

# # #


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Air pollution linked to cardiovascular risk indices in healthy young adults
4. More proof needed of safety and quality of electronic personal health records
5. Health care incentive model offers collaborative approach
6. Loneliness is bad for your health
7. Mailman School of Public Health study examines link between racial discrimination and substance use
8. Green Tea May Brew Up Healthier Skin
9. For Health Info, Women Often Turn to the Web
10. Record Number of Americans Lack Health Insurance
11. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...it lowered bad cholesterol more effectively than Z...s) -- After nearly a year of review, U.S. health o...tinued use of the controversial cholesterol-loweri...istration said there was no significant difference...ng Vytorin and patients taking the drug Zocor. ,...
(Date:1/8/2009)... of local dance students will dance to raise money...POLIS, Jan. 8 , , , WHO: ...ll show off their talent in the 3rd annual Dance,...y Dance Arts Centre. The, event w...or., Participants raise money th...
(Date:1/8/2009)...AGO, Jan. 8 Allscripts-M...pts Healthcare Solutions, Inc. (Allscripts or,the...or the three and six,months ended November 30, 20...n/prnh/20061005/ALLSCRIPTSLOGO-b ) , The Co... November 30, 2008,include results from legacy Al...
(Date:1/8/2009)...FRANCISCO, Jan. 8 Mediva... David Hung, M.D., president and chief,executive ...an Healthcare,Conference on Wednesday, January 14...ancis Hotel in San Francisco. , Dr. Hung wi...cal,development programs for Dimebon for Alzheime...
Breaking Medicine News(10 mins):Health News:FDA Backs Cholesterol Drug Vytorin 2Health News:Dance With Courage to Benefit Camp Courage 2Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 2Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 3Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 4Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 5Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 6Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 7Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 8Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 9Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 10Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 11Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 12Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 13Health News:Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference 2
...ement has fuelled a booming industry and turned pl...than 22,000 operations were carried out on men and.... The number of women // opting for cosmetic surge...interest also increased, particularly for facial a...
...history of heart problems and consume anti-impoten...ng their eyesight damaged, according to a study co...chers suggest that taking viagra may result in the...ow, giving rise to tissue damage. The British Medi...
... increase in the incidence of Polio in Bihar state...tate health officials. The state stands unparalle... country. // A massive polio immunization programm...ildren less than 5 years of age has been launched ...
...lu pandemic is on the rise as there are new report...agglutinin antigen fragment of the bird flu virus ...e to antiflu drugs shown by these viruses. Scienti..., in which the antibodies is collected from the bl...
Other Medicine News:Health News:UK Plastic surgeons cash in as cosmetic operations soar 2Health News:UK Plastic surgeons cash in as cosmetic operations soar 3Health News:Bihar Health Officials Worried As Polio Cases Soar 2
(Date:1/7/2009)... , FREDERICK, Md., Jan. 7 ImQue...bmission of an IND application to the Food and Dru... for their lead pyrimidinedione HIV inhibitor IQP-... studies in the first quarter of 2009. IQP-0410 is...marily acts as a nonnucleoside reverse transcripta...
(Date:1/6/2009)... , Program Expands on Successful Results from p... Jan. 7 Vital Therapies, Inc. (VTI...ease, today announced patient enrollment has begun... 2 clinical trial that will study the Extracorpore...atients with Acute Liver Failure (ALF) under three...
(Date:1/6/2009)... , ROCKVILLE, Md., Jan. 6 /PRNewswire-USNewswir...utical company focused on diseases of epidemic pot...candidate for the treatment of tuberculosis (TB), ...wly awarded clinical program contract to Dynport V...e contract, awarded by the National Institute of A...
(Date:1/5/2009)... , SAN DIEGO, Jan. 5 Cylene Pha... a Phase I clinical trial of its oral CK2 protein ...ed solid tumors, Castleman,s disease, or multiple ...calating trial are determination of safety, tolera... appropriate dose for Phase II trials. In addition...
Breaking Medicine Technology:ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 3Greenway Medical Technologies EHR Solution PrimeSuite Wins Three Best in KLAS Awards 32167 1Greenway Medical Technologies EHR Solution PrimeSuite Wins Three Best in KLAS Awards 32167 2Greenway Medical Technologies EHR Solution PrimeSuite Wins Three Best in KLAS Awards 32167 3Greenway Medical Technologies EHR Solution PrimeSuite Wins Three Best in KLAS Awards 32167 4Sage Software Healthcare Appoints Kathleen Henry Senior Vice President Customer Service 32165 1Sage Software Healthcare Appoints Kathleen Henry Senior Vice President Customer Service 32165 2Immune System Works Better at Night 32164 1Immune System Works Better at Night 32164 2Later School Start Time Cuts Teens Car Crash Risk 32162 1Later School Start Time Cuts Teens Car Crash Risk 32162 2Later School Start Time Cuts Teens Car Crash Risk 32162 3
...)--Jun 4, 2007 - Introgen Therapeutics, Inc.,(NASD... today,reported updated Phase 2 data demonstrating...umor responses and increased,survival following AD...us cell carcinoma of the head and neck. The data (... meeting of the American,Society of Clinical Oncol...
...se 2 Clinical Data Published at the American,Socie...GO, June 04, 2007 /PRNewswire-FirstCall/ -- Pharmi...m its Phase II,multi-center clinical study of Amr...nthracycline currently in development,for the trea...dicate favorable interim results in terms of respo...
Other Medicine Technology:Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 2Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 3Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 4Pharmion's Amrubicin Shows Encouraging Results Compared to Standard,of Care in Second Line Treatment of Small Cell Lung Cancer 2Pharmion's Amrubicin Shows Encouraging Results Compared to Standard,of Care in Second Line Treatment of Small Cell Lung Cancer 3Pharmion's Amrubicin Shows Encouraging Results Compared to Standard,of Care in Second Line Treatment of Small Cell Lung Cancer 4
The 15 and 18 Sony Flat Screen Monitors with articulating arm can be used in conjunction with existing surgical monitors or as replacements.
Colour video monitors.
The A3 3-Chip Camera includes digital processing, seamless autoshutter, industry-leading reliability, white balance with memory function, ease of operation, and a 2 year warranty.
Camera and light source in one compact "Plug-and-Play" device.
Medicine Products: